RA
STAA icon

Rise Advisors’s STAAR Surgical STAA Stock Holding History

Rise Advisors’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50
Closed -$1.34K – 1250
2025
Q3 		$1.34K Hold
50
– – ﹤0.01% 1233
2025
Q2 		$839 Sell
50
-10
-17% -$176 ﹤0.01% 1316
2025
Q1 		$1.06K Hold
60
– – ﹤0.01% 1242
2024
Q4 		$1.46K Hold
60
– – ﹤0.01% 1079
2024
Q3 		$2.23K Hold
60
– – ﹤0.01% 1124
2024
Q2 		$2.86K Hold
60
– – ﹤0.01% 1106
2024
Q1 		$2.3K Hold
60
– – ﹤0.01% 1132
2023
Q4 		$1.87K Hold
60
– – ﹤0.01% 471
2023
Q3 		$2.41K Sell
60
-216
-78% -$10.1K ﹤0.01% 447
2023
Q2 		$14.5K Hold
276
– – 0.01% 288
2023
Q1 		$17.6K Hold
276
– – 0.01% 272
2022
Q4 		$13.4K Hold
276
– – 0.01% 305
2022
Q3 		$19K Hold
276
– – 0.02% 256
2022
Q2 		$20K Hold
276
– – 0.02% 239
2022
Q1 		$22K Hold
276
– – 0.02% 235
2021
Q4 		$25.2K Buy
+276
New +$29.6K 0.02% 220

Other funds holding STAA

BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rise Advisors's STAA Position: Q4 2025 in Review

Rise Advisors sold out of STAAR Surgical (STAA) in Q4 2025, closing a stake of 50 shares — an estimated $1.34K sold.

Rise Advisors first reported a position in STAA in Q4 2021 and held it in 16 quarters. The position peaked at $25.2K in Q4 2021. 201 funds tracked by Wall St. Rank hold STAA as of Q4 2025.

  • Rise Advisors reported no remaining STAAR Surgical position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 50 STAAR Surgical shares in Q4 2025, an estimated $1.34K.
  • Rise Advisors first reported a position in STAAR Surgical in Q4 2021 and held it in 16 quarters.
  • Rise Advisors's STAAR Surgical position peaked at $25.2K in Q4 2021.
  • 201 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.